| 11/10/2026 8:19 AM | Scinai Immunotherapeutics (1611747) Filer | Form 424B3 | |
| 11/09/2026 11:15 PM | Scinai Immunotherapeutics (1611747) Filer | Form EFFECT | |
| 11/09/2026 5:05 AM | Scinai Immunotherapeutics (1611747) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/28/2026 3:02 PM | Scinai Immunotherapeutics (1611747) Filer | Form F-3 Registration statement for securities of certain foreign private issuers | |
| 10/20/2026 9:09 AM | Scinai Immunotherapeutics (1611747) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/16/2026 9:05 AM | Scinai Immunotherapeutics (1611747) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/15/2026 8:40 AM | Scinai Immunotherapeutics (1611747) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/13/2026 6:50 AM | Scinai Immunotherapeutics (1611747) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/05/2026 11:15 PM | Scinai Immunotherapeutics (1611747) Filer | Form EFFECT | |
| 09/24/2026 3:22 PM | Scinai Immunotherapeutics (1611747) Filer | Form F-1 Registration statement for securities of certain foreign private issuers | |
| 09/21/2026 6:00 AM | Scinai Immunotherapeutics (1611747) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for SCNI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Scinai Immunotherapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 09/08/2026 8:54 AM | Scinai Immunotherapeutics (1611747) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/30/2026 11:15 PM | Scinai Immunotherapeutics (1611747) Filer | Form EFFECT | |
| 08/27/2026 10:35 AM | Scinai Immunotherapeutics (1611747) Filer | Form POS AM | |
| 08/26/2026 7:13 AM | Scinai Immunotherapeutics (1611747) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/19/2026 8:25 AM | Scinai Immunotherapeutics (1611747) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/09/2026 8:58 AM | LCK JNK 1 LLC (2055074) Filed by Scinai Immunotherapeutics (1611747) Subject | Form SCHEDULE 13G/A | |
| 07/01/2026 4:29 PM | Scinai Immunotherapeutics (1611747) Subject STONE DANIEL E. (1948744) Filed by | Form SCHEDULE 13G/A | |
| 06/18/2026 1:48 PM | Reichman Amir (1960199) Reporting Scinai Immunotherapeutics (1611747) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2026 1:51 PM | GERMAIN MARK (1195498) Reporting Scinai Immunotherapeutics (1611747) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 5:01 AM | Scinai Immunotherapeutics (1611747) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/15/2026 5:48 AM | Scinai Immunotherapeutics (1611747) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/08/2026 11:57 AM | Scinai Immunotherapeutics (1611747) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/19/2026 11:15 PM | Scinai Immunotherapeutics (1611747) Filer | Form EFFECT | |
| 05/12/2026 4:28 PM | Scinai Immunotherapeutics (1611747) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/08/2026 6:22 AM | Scinai Immunotherapeutics (1611747) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/27/2026 3:00 PM | Scinai Immunotherapeutics (1611747) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/01/2026 6:36 AM | Scinai Immunotherapeutics (1611747) Filer | Form 20-F Registration statement / Annual report / Transition report | |
| 03/26/2026 7:41 AM | Mark Elad (1960205) Reporting Scinai Immunotherapeutics (1611747) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/23/2026 8:16 AM | Scinai Immunotherapeutics (1611747) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/19/2026 9:08 AM | Scinai Immunotherapeutics (1611747) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/18/2026 8:59 AM | Green Jay (1960710) Reporting Scinai Immunotherapeutics (1611747) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 9:01 AM | GERMAIN MARK (1195498) Reporting Scinai Immunotherapeutics (1611747) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 9:05 AM | Moed Samuel J (1561017) Reporting Scinai Immunotherapeutics (1611747) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 9:06 AM | Ben-Or Uri (1793464) Reporting Scinai Immunotherapeutics (1611747) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 9:08 AM | MARGOLIN YAEL (1868637) Reporting Scinai Immunotherapeutics (1611747) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 8:53 AM | Reichman Amir (1960199) Reporting Scinai Immunotherapeutics (1611747) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 8:35 AM | Raviv Adi (1098565) Reporting Scinai Immunotherapeutics (1611747) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/25/2026 9:08 AM | Scinai Immunotherapeutics (1611747) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/17/2026 12:14 PM | Scinai Immunotherapeutics (1611747) Subject STONE DANIEL E. (1948744) Filed by | Form SCHEDULE 13G/A | |
| 02/17/2026 7:46 AM | Scinai Immunotherapeutics (1611747) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
What the hell is going on? (Ad) Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway.
The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December.
Watch Porter Stansberry's full broadcast to see which companies could be affected. Watch Porter Stansberry's full broadcast on the coming dollar reset now |
| 12/23/2025 3:01 PM | Scinai Immunotherapeutics (1611747) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/02/2025 10:00 AM | Scinai Immunotherapeutics (1611747) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |